Sacramento, CA -- March 07, 2018 -- InvestorsHub NewsWire -- A
new report has been published on Innovest Global, Inc. (OTC Pink:
IVST). Innovest Global, Inc. is a diversified holding company that
focuses on acquiring niche, high-growth businesses that are capable
of generating significant annual revenue. The company’s planned
subsidiaries operate across telehealth, biotech, commercial energy,
business-to-business distribution, national call center and auto
sales.
The report provides an overview of Innovest Global, Inc., its
subsidiaries, financials, industry analysis and more. The content
also covers the global outlook for the biotechnology industry.
Global Biotech Industry Forecast to Reach $727.10
Billion By 2025
The fight against the next major outbreak will heavily rely on
biotechnology in order to effectively find a treatment or cure.
This makes biotech one of the key frontiers against emerging health
threats, such as viruses and drug-resistant bacteria.
Without an aggressive effort to research and develop (R&D)
treatments to fight some of the largest threats to humanity, we
risk reliving deadly periods in history such as the “Black Death.”
The pandemic wiped out 50 million people in the 14th
century, which equated to 60% of Europe’s population at the time of
the plague outbreak.
According to Grand View Research, Inc., the global
biotechnology market is forecast to hit $727.10 billion by 2025.
The firm notes that the growth will most likely be generated by
regenerative medicines and genetics in diagnostics. Grand View
further notes that technological advances are helping biotech
companies with greater R&D and clinical testing capabilities.
Overall, this will help with advancing treatments and research
methods.
Innovest Launching New Biotech and Health Sciences
Division This Spring, Will Be Headquartered in Los Angeles,
CA
Innovest Global, Inc. recently announced that it is preparing to
launch a new biotechnology and health sciences division this
spring, which will be headquartered in Los Angeles, CA. The
new division will be led by world-renowned
neuroscientist, Dr. Dwain Morris-Irvin.
Dr. Morris-Irvin received his PhD from the UCLA School of
Medicine and Masters in Public Health from UCLA School of Public
Health. Furthermore, the distinguished neuroscientist trained at
The Wallenberg Neuroscience Center at Lund University in Lund,
Sweden.
“Dr. Morris-Irvin is an active participant in many Biotechnology
and Health Science endeavors, and is an expert including patent
generation in such areas as treatments for Parkinson’s, brain
cancer, and even cosmetic application of advanced bioscience,” said
Dan Martin, CEO of Innovest Global.
The official Twitter page of Innovest Global, Inc. has
recently announced a variety of exciting meetings with potential
acquisition targets, business owners, and local congressional
representatives. The U.S. Congressman in Innovest’s district in
Ohio has recently met with Dan Martin and the Innovest Global team
a couple of times over the past month, as they discuss legislative
matters and the benefits of the Trump tax cuts. However, this also
shows that management continues to have the company on the path to
success. You certainly do not hear about any other congressional
leaders are visiting Pink Sheet companies. This shows the company
is not only on the right track, but also turning heads.
Innovest announced that it has generated revenues of
$388,000, through half of the first quarter 2018. This beat
management’s estimates by 55% and puts the company well on its way
to beating its goal of reporting $500,000 in revenue per
quarter.
Management has also noted in recent press releases that the
company continues to search for quality acquisitions, as it
processes its growing pipeline. Furthermore, Innovest is currently
vetting PCAOB auditors to be engaged with the company and
assist with auditing the financials. This is in addition to the
fact that the company’s corporate counsel is an official OTCQX
sponsor, which positions the company to continue pursuing uplisting
endeavors that have been laid out in previous press
releases.
For more information on Innovest Global, Inc., please
visit http://innovestglobal.com and http://spotlightgrowth.com/index.php/2018/03/06/innovest-global-inc-otc-pink-ivst-enters-biotech-and-health-sciences-industry-after-forming-new-subsidiary-new-divisions-headquarters-will-be-los-angeles/
SpotlightGrowth.com is a digital hub for micro-caps,
small-caps, crowdfunding, cryptocurrency, and other emerging growth
investors. SpotlightGrowth.com serves as our media
subsidiary and provides insights on small cap companies.
Disclaimer:
Spotlight Growth is compensated, either directly or via a third
party, to provide investor relations services for its
clients. Spotlight Growth creates exposure for companies
through a customized marketing strategy, including design of
promotional material, the drafting and editing of press releases
and media placement.
All information on featured companies is provided by the
companies profiled, or is available from public sources. Spotlight
Growth and its employees are not a Registered Investment Advisor,
Broker Dealer or a member of any association for other research
providers in any jurisdiction whatsoever and we are not qualified
to give financial advice. The information contained herein is based
on external sources that Spotlight Growth believes to be reliable,
but its accuracy is not guaranteed. Spotlight Growth may
create reports and content that has been compensated by a company
or third-parties, or for purposes of self-marketing. Spotlight
Growth was compensated two thousand eight hundred dollars cash and
fifty thousand restricted shares for the creation and dissemination
of this content.
This material does not represent an investment solicitation.
Certain statements contained herein constitute “forward-looking
statements” within the meaning of the Private Securities Litigation
Reform Act of 1995. Such statements may include, without
limitation, statements with respect to the Company’s plans and
objectives, projections, expectations and intentions. These
forward-looking statements are based on current expectations,
estimates and projections about the Company’s industry,
management’s beliefs and certain assumptions made by
management.
The above communication, the attachments and external Internet
links provided are intended for informational purposes only and are
not to be interpreted by the recipient as a solicitation to
participate in securities offerings. Investments referenced
may not be suitable for all investors and may not be permissible in
certain jurisdictions.
Spotlight Growth and its affiliates, officers, directors, and
employees may have bought or sold or may buy or sell shares in the
companies discussed herein, which may be acquired prior, during or
after the publication of these marketing materials. Spotlight
Growth, its affiliates, officers, directors, and employees may sell
the stock of said companies at any time and may profit in the event
those shares rise in value. For more information on our
disclosures, please
visit: http://spotlightgrowth.com/index.php/disclosures/
Matt Rego 9165257147 mrego@spotlightgrowth.com
Innovest Global (CE) (USOTC:IVST)
Historical Stock Chart
From Mar 2024 to Apr 2024
Innovest Global (CE) (USOTC:IVST)
Historical Stock Chart
From Apr 2023 to Apr 2024
